Commercialization Launch Readiness
Verastem was referred to SVA Consulting as a Phase 3 biopharmaceutical company with 30 employees and promising data. SVA was brought in to help Verastem Oncology with the launch planning around the operations and processes, as well as helping to plan all of Verastem’s systems, which prior to SVA, their “systems” were email and a server.
ELS Program Management
Exact Sciences was referred to SVA Consulting when they were a startup medical device company. In lightning speed of 19 months, Exact Sciences grew from 36 employees to over 700, moving from developing Cologuard, their pre-screening test for colon rectal cancer, to human trials, FDA approval and then to the international marketplace.
MyoKardia engaged SVA Consulting at the end of its Phase 3 program to evaluate the commercial capabilities of their financial systems. The question at hand was whether MyoKardia should take on the implementation of a new ERP system, or whether their current ERP system would support a commercial company.